| Quarterly Financials | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 1,566 | 1,576 | 1,918 | 1,839 | 1,797 | 1,853 | 2,156 | 2,209 | 2,032 | 2,091 | 2,326 | 2,307 | 1,768 | 2,252 | 2,234 | 2,421 | 2,381 | 2,515 | 2,662 | 2,750 | 2,699 | 2,835 | 3,202 | 956 | 849 | 933 | 1,108 | 978 | 6,122 | 1,122 | 1,083 | 1,032 | 1,111 | 1,226 | 1,214 |
| Expenses | 1,517 | 1,428 | 1,643 | 1,521 | 1,651 | 1,714 | 1,891 | 1,851 | 1,806 | 1,842 | 1,955 | 1,878 | 1,618 | 1,972 | 1,900 | 2,070 | 2,091 | 2,162 | 2,253 | 2,267 | 2,370 | 2,498 | 2,744 | 687 | 747 | 856 | 806 | 861 | 841 | 869 | 888 | 845 | 881 | 962 | 1,012 |
| EBITDA | 49 | 148 | 276 | 318 | 146 | 139 | 265 | 358 | 226 | 249 | 371 | 429 | 150 | 280 | 335 | 351 | 290 | 353 | 409 | 482 | 329 | 337 | 458 | 269 | 102 | 78 | 302 | 117 | 5,281 | 252 | 195 | 187 | 230 | 264 | 202 |
| Operating Profit % | 3 % | 9 % | 9 % | 15 % | 7 % | 7 % | 12 % | 16 % | 11 % | 12 % | 16 % | 18 % | 8 % | 12 % | 15 % | 13 % | 12 % | 14 % | 15 % | 17 % | 11 % | 11 % | 14 % | 15 % | 11 % | 8 % | 16 % | 12 % | 16 % | 20 % | 15 % | 16 % | 18 % | 20 % | 15 % |
| Depreciation | 79 | 95 | 68 | 56 | 74 | 76 | 79 | 78 | 126 | 149 | 140 | 171 | 155 | 153 | 157 | 153 | 153 | 156 | 161 | 170 | 175 | 189 | 198 | 54 | 51 | 54 | 57 | 58 | 60 | 62 | 62 | 64 | 63 | 66 | 68 |
| Interest | 43 | 46 | 49 | 47 | 40 | 40 | 56 | 55 | 88 | 88 | 72 | 112 | 80 | 75 | 62 | 77 | 67 | 61 | 67 | 62 | 69 | 77 | 87 | 25 | 25 | 30 | 25 | 30 | 29 | 32 | 31 | 32 | 31 | 31 | 32 |
| Profit Before Tax | -73 | 7 | 158 | 216 | 32 | 24 | 130 | 224 | 12 | 12 | 160 | 146 | -85 | 53 | 115 | 122 | 71 | 135 | 181 | 250 | 85 | 71 | 173 | 190 | 26 | -7 | 221 | 28 | 5,191 | 159 | 102 | 91 | 136 | 167 | 103 |
| Tax | 7 | 9 | -1 | 10 | 12 | 10 | 17 | 4 | 2 | 5 | 8 | -0 | 4 | 10 | 8 | 5 | 11 | 8 | 13 | 4 | 6 | 17 | 14 | 7 | 6 | 8 | 11 | 31 | 39 | 53 | 38 | 5 | 43 | 46 | 44 |
| Net Profit | -80 | -3 | 159 | 205 | 20 | 14 | 113 | 220 | 10 | 7 | 151 | 146 | -89 | 42 | 107 | 117 | 60 | 128 | 168 | 246 | 80 | 54 | 159 | 183 | 20 | -15 | 209 | -2 | 5,152 | 106 | 64 | 86 | 94 | 121 | 59 |
| EPS in ₹ | -1.66 | 0.01 | 3.33 | 4.07 | 0.25 | 0.22 | 2.00 | 4.10 | 0.06 | 0.06 | 2.78 | 2.61 | -1.67 | 0.66 | 1.86 | 2.12 | 0.89 | 2.15 | 2.98 | 4.55 | 1.38 | 0.93 | 2.80 | 3.43 | 0.10 | -0.62 | 3.60 | -0.48 | 103.34 | 1.94 | 1.14 | 1.59 | 1.67 | 2.13 | 1.02 |
Aster DM Healthcare
Aster DM Healthcare
654.30
+4.85
(0.75%)
Market Cap
33,900.66 Cr
PE Ratio
93.71
Volume
3,62,377.00
Day High - Low
655.30 - 639.05
52W High-Low
732.20 - 387.10
There are new updates from the company18 hrs ago
View
Key Fundamentals
Market Cap
33,900.66 Cr
EPS
107.98
PE Ratio
93.71
PB Ratio
8.04
Book Value
80.76
EBITDA
912.80
Dividend Yield
0.74 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
9.22
Debt to Equity
0.47
Analyst Rating and Forecast
- By Refinitiv from9 analysts
Actual
Company News
View All News
Aster DM Healthcare's subsidiary unit is actively planning to raise capital from potential investors, marking a strategic move to strengthen its financial position and support business expansion.
Aster DM Healthcare delivered 13% revenue growth to INR 1,186 crore in Q3 FY26, with operating EBITDA up 11% to INR 224 crore. Combined with QCIL, the platform achieved 15% revenue growth to INR 2,366 crore.
Aster DM Healthcare reports Q3FY26 results with revenue of ₹665.75 crores. Board approves ESOP Scheme 2026, loan conversion of ₹129.35 crores, and merger proceedings with Quality Care India Limited.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
7,852.00 | #1 1,12,899.71 | 59.95 | #1 21,994.30 | 14.76 | #1 1,505 | 36.08 | 75.04 | |
1,096.50 | 1,06,664.16 | 76.13 | 7,184.10 | #1 28.65 | 1,076 | 26.01 | 67.90 | |
951.40 | 71,826.72 | 74.21 | 7,849.70 | 13.25 | 809 | -22.38 | 70.90 | |
1,820.20 | 37,197.75 | 48.51 | 5,575.00 | 12.29 | 790 | -34.33 | 53.50 | |
654.30 | #5 33,900.66 | #9 93.71 | #5 4,286.70 | #6 15.12 | #7 337 | #5 -8.85 | 67.53 | |
1,144.10 | 30,752.31 | 60.73 | 3,771.40 | 12.59 | 481 | -33.52 | 54.33 | |
743.05 | 29,732.32 | 94.40 | 3,067.00 | 21.98 | 415 | -43.89 | 70.31 | |
449.25 | 14,217.41 | 88.33 | 1,757.00 | 27.64 | 110 | #1 54.61 | 42.95 | |
1,192.60 | 12,111.94 | 47.20 | 1,566.90 | 17.46 | 244 | 7.26 | 50.87 | |
1,299.80 | 8,522.27 | #1 45.30 | 1,290.20 | 17.77 | 194 | -18.58 | 56.12 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
15.12 %
Net Income Growth
64.48 %
Cash Flow Change
169.34 %
ROE
126.54 %
ROCE
87.55 %
EBITDA Margin (Avg.)
31.50 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Fixed Assets | 3,520 | 3,738 | 4,289 | 7,124 | 6,749 | 7,009 | 9,052 | 3,175 | 3,920 |
| Current Assets | 2,473 | 2,869 | 3,617 | 4,096 | 3,629 | 4,097 | 4,922 | 14,165 | 1,902 |
| Capital Work in Progress | 290 | 402 | 550 | 736 | 934 | 998 | 279 | 170 | 293 |
| Investments | 32 | 38 | 22 | 34 | 63 | 45 | 80 | 17 | 245 |
| Other Assets | 2,966 | 3,307 | 4,076 | 4,544 | 3,898 | 4,495 | 5,470 | 14,629 | 2,148 |
| Total Liabilities | 6,807 | 7,484 | 8,936 | 12,438 | 11,644 | 12,546 | 14,881 | 17,991 | 6,606 |
| Current Liabilities | 2,201 | 2,224 | 2,668 | 3,722 | 3,196 | 3,559 | 4,655 | 11,288 | 879 |
| Non Current Liabilities | 2,355 | 2,071 | 2,589 | 4,997 | 4,614 | 4,505 | 5,366 | 1,673 | 2,076 |
| Total Equity | 2,251 | 3,190 | 3,680 | 3,719 | 3,834 | 4,483 | 4,861 | 5,030 | 3,651 |
| Reserve & Surplus | 1,034 | 1,953 | 2,334 | 2,401 | 2,501 | 3,080 | 3,574 | 3,686 | 2,554 |
| Share Capital | 403 | 505 | 505 | 497 | 497 | 500 | 500 | 500 | 500 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 5 | -122 | 61 | 33 | -110 | 120 | 65 | 66 | 332 | 82 |
| Investing Activities | -439 | -775 | -1,136 | -522 | -702 | -658 | -333 | -563 | -951 | -878 | 6,015 |
| Operating Activities | 236 | 203 | 361 | 537 | 601 | 1,223 | 1,569 | 1,314 | 1,834 | 158 | 425 |
| Financing Activities | 203 | 578 | 654 | 46 | 134 | -675 | -1,116 | -686 | -817 | 1,053 | -6,358 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Apr 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 37.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.88 % | 41.89 % | 40.38 % | 40.39 % | 40.39 % | 40.39 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 33.09 % | 29.09 % | 29.09 % | 40.21 % | 29.09 % | 33.48 % | 27.08 % | 23.85 % | 22.62 % | 21.66 % | 11.86 % | 19.64 % | 18.72 % | 18.46 % |
| DIIs | 7.81 % | 8.73 % | 7.78 % | 7.87 % | 8.12 % | 9.62 % | 8.94 % | 8.93 % | 8.94 % | 8.56 % | 7.64 % | 7.15 % | 13.70 % | 16.35 % | 20.91 % | 22.91 % | 24.59 % | 24.09 % | 25.28 % | 26.32 % | 26.12 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 3.70 % | 4.44 % | 4.21 % | 4.33 % | 3.92 % | 3.70 % | 3.43 % | 3.34 % | 3.18 % | 3.39 % | 3.15 % | 2.96 % | 3.09 % | 6.98 % | 5.94 % | 5.04 % | 4.38 % | 4.12 % | 3.94 % | 3.86 % | 4.07 % |
| Others | 50.61 % | 48.94 % | 50.12 % | 49.92 % | 50.08 % | 48.80 % | 49.75 % | 16.76 % | 16.92 % | 17.08 % | 7.11 % | 18.93 % | 7.85 % | 7.72 % | 7.42 % | 7.55 % | 7.49 % | 19.56 % | 10.76 % | 10.70 % | 10.95 % |
| No of Share Holders | 0 | 78,719 | 93,506 | 87,804 | 80,746 | 80,427 | 78,374 | 80,913 | 82,129 | 71,379 | 67,673 | 67,331 | 80,931 | 2,06,660 | 1,74,171 | 1,59,038 | 1,54,014 | 1,51,664 | 1,48,139 | 1,47,304 | 1,46,998 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 120 | 5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.82 | 0.77 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 10 Mar 2026 |  Extraordinary General Meeting | NA | 10 Mar 2026 | 546.50 | 649.45 |
| 31 Aug 2023 |  Annual General Meeting | NA | 31 Aug 2023 | 312.45 | 331.20 |
| 23 Apr 2024 |  Dividend | ₹ 118.00 /share | 23 Apr 2024 | 475.25 | 513.35 |
| 22 Aug 2024 | Dividend | ₹ 2.00 /share | 22 Aug 2024 | 375.20 | 401.15 |
| 29 Aug 2024 | Annual General Meeting | NA | 29 Aug 2024 | 379.30 | 409.90 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 427.95 | 405.20 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 494.65 | 485.30 |
| 10 Feb 2025 | Dividend | ₹ 4.00 /share | 10 Feb 2025 | 485.30 | 473.20 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 550.10 | 584.15 |
| 30 Jul 2025 | Quarterly Result Announcement | NA | 30 Jul 2025 | 595.05 | 590.95 |
| 28 Aug 2025 | Dividend | ₹ 1.00 /share | 28 Aug 2025 | 584.15 | 601.00 |
| 04 Sept 2025 | Annual General Meeting | NA | 04 Sept 2025 | 590.95 | 620.00 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 697.60 | 688.70 |
| 30 Jan 2026 | Quarterly Result Announcement | NA | 30 Jan 2026 | 576.00 | 539.15 |
Announcements
Announcement Under Regulation 30 Of SEBI (LODR)
18 hrs ago
18 hrs agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20116 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Feb 05, 2026Notice Of Meeting Of The Unsecured Creditors Of Aster DM Healthcare Limited To Be Convened As Per The Directions Provided In The Order Of The Honble NCLT HyderabadFeb 04, 2026
Feb 04, 2026Notice Of Meeting Of The Equity Shareholders Of Aster DM Healthcare Limited To Be Convened As Per The Directions Provided In The Order Of The Honble NCLT HyderabadFeb 04, 2026
Feb 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Feb 02, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2026
Jan 31, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2026
Jan 30, 2026UpdatesJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-AcquisitionJan 30, 2026
Jan 30, 2026Board Meeting Outcome for Outcome Of Board MeetingJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-AcquisitionJan 29, 2026
Jan 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 27, 2026
Jan 27, 2026Board Meeting Intimation for Approving Unaudited Financial Results For The Quarter Ended December 31 2025Jan 23, 2026
Jan 23, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 23, 2026
Jan 23, 2026Receipt Of NCLT Order Dated January 21 2026Jan 22, 2026
Jan 22, 2026Monthly Report On Special Window Re-Lodgement Of SharesJan 07, 2026
Jan 07, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 03, 2026
Jan 03, 2026Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 31, 2025
Dec 31, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Clarification Regarding Media ReleaseDec 20, 2025
Dec 20, 2025Monthly Report On Special Window For Re-Lodgement Of SharesDec 08, 2025
Dec 08, 2025Monthly Report On Special Window For Re-Lodgement Of SharesDec 08, 2025
Dec 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 03, 2025
Dec 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 23, 2025
Nov 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 23, 2025
Nov 23, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2025
Nov 19, 2025Receipt Of RD Order For Change In The Registered Office And Consequent Alteration Of Memorandum Of Association Of The CompanyNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Nov 14, 2025Monthly Report On Special Window Re-Lodgement Of SharesNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-CessationNov 09, 2025
Nov 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 06, 2025
Nov 06, 2025Results - Financial Results For Sep 30 2025Nov 06, 2025
Nov 06, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 67.53
ATR(14)
Less Volatile 19.90
STOCH(9,6)
Overbought 88.58
STOCH RSI(14)
Overbought 90.19
MACD(12,26)
Bullish 6.78
ADX(14)
Strong Trend 33.20
UO(9)
Bearish 65.53
ROC(12)
Uptrend And Accelerating 12.68
WillR(14)
Overbought -4.34
About Aster DM Healthcare
Aster DM Healthcare is a healthcare service provider operating in the GCC and India. Founded in 1987 by Dr. Azad Moopen, the company offers a range of healthcare services through a network of hospitals, clinics, pharmacies, and labs. As of March 2023, Aster DM Healthcare operates 32 hospitals, 127 clinics,...more
Listing Date
26 Feb, 2018(8 Years,
1 days)
Chairperson NameMandayapurath Azad Moopen
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
